Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Here’s Why

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped up prior to trading on Thursday . The stock had previously closed at $9.19, but opened at $9.83. Curaleaf shares last traded at $9.67, with a volume of 13,799 shares.

Analyst Ratings Changes

Several research analysts have commented on the stock. Zacks Research raised shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Citigroup reaffirmed a “buy” rating on shares of Curaleaf in a report on Thursday, August 6th. Three equities research analysts have rated the stock with a Strong Buy rating and two have issued a Buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Strong Buy”.

Curaleaf Price Performance

The business has a 50 day moving average of $7.62 and a 200 day moving average of $7.86. The company has a market cap of $2.33 billion, a PE ratio of -76.83 and a beta of 1.56. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.52 and a quick ratio of 0.73.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.25. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%.The company had revenue of $340.10 million for the quarter, compared to analysts’ expectations of $332.00 million. As a group, research analysts predict that Curaleaf Holdings, Inc. will post 0.01 EPS for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.